Literature DB >> 19119700

Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials.

Harissios Vliagoftis1, Vasilios D Kouranos, Gregoria I Betsi, Matthew E Falagas.   

Abstract

OBJECTIVE: To evaluate the clinical evidence for the use of probiotics as a therapeutic modality for allergic rhinitis (AR) and asthma. DATA SOURCES: PubMed was searched to identify randomized controlled trials (RCTs) that studied the effects of probiotics on AR (n = 12) and asthma (n = 4). STUDY SELECTION: RCTs that studied the effects of probiotics administration on the treatment but not the prevention of AR and asthma were selected for inclusion in this review.
RESULTS: Nine of the 12 RCTs that evaluated clinical outcomes in AR showed an improvement due to the use of probiotics. All the RCTs that studied perennial AR showed lower symptom scoring and medication use with the use of probiotics compared with placebo. Also, 5 of the 8 RCTs that referred to seasonal AR suggested an improvement in clinical outcomes. Nine RCTs that reported various immunologic measurements of allergy found no significant probiotic effects. The RCTs that studied the effect of probiotic administration on the treatment of asthma showed no positive effects.
CONCLUSIONS: Probiotics may have a beneficial effect in AR by reducing symptom severity and medication use. Many more good-quality studies are needed to resolve this issue.

Entities:  

Mesh:

Year:  2008        PMID: 19119700     DOI: 10.1016/S1081-1206(10)60219-0

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  45 in total

Review 1.  Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data.

Authors:  O Ozdemir
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

2.  Looking after local nasal and sinus mucosa in health, disease and after surgery.

Authors:  S K Kacker
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-10-12

3.  Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study).

Authors:  D J Costa; P Marteau; M Amouyal; L K Poulsen; E Hamelmann; M Cazaubiel; B Housez; S Leuillet; M Stavnsbjerg; P Molimard; S Courau; J Bousquet
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

Review 4.  Treatments for food allergy: how close are we?

Authors:  Julie Wang; Hugh A Sampson
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 5.  A systematic review and meta-analysis of probiotics for the treatment of allergic rhinitis.

Authors:  Alexander E Zajac; Austin S Adams; Justin H Turner
Journal:  Int Forum Allergy Rhinol       Date:  2015-04-20       Impact factor: 3.858

Review 6.  Adjuvants for allergy vaccines.

Authors:  Philippe Moingeon
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

7.  Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.

Authors:  E Vintiñi; J Villena; S Alvarez; M Medina
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

8.  The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model.

Authors:  Jinho Yu; Seong-Ok Jang; Byoung-Ju Kim; Young-Hwa Song; Ji-Won Kwon; Mi-Jin Kang; Won-Ah Choi; Hyun-Don Jung; Soo-Jong Hong
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-19       Impact factor: 5.764

Review 9.  Microbial ecology and host-microbiota interactions during early life stages.

Authors:  Maria Carmen Collado; Maria Cernada; Christine Baüerl; Máximo Vento; Gaspar Pérez-Martínez
Journal:  Gut Microbes       Date:  2012-06-29

10.  Probiotics in Disease Prevention and Treatment.

Authors:  Yuying Liu; Dat Q Tran; J Marc Rhoads
Journal:  J Clin Pharmacol       Date:  2018-10       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.